Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
Author(s) -
Zeina Habib,
Suzanne Havstad,
Karen Wells,
George Divine,
Manel Pladevall,
L. Keoki Williams
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-1385
Subject(s) - thiazolidinedione , type 2 diabetes mellitus , medicine , diabetes mellitus , longitudinal data , longitudinal study , geology , type 2 diabetes , endocrinology , demography , pathology , sociology
Thiazolidinedione (TZD) use has recently been associated with an increased risk of fractures.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom